Literature DB >> 29552216

lncRNA BANCR promotes EMT in PTC via the Raf/MEK/ERK signaling pathway.

Yuanyuan Wang1, Jiaojiao Gu1, Xiangde Lin2, Wei Yan1, Wenchao Yang2, Guoyang Wu1.   

Abstract

Thyroid cancer is one of the most common types of cancer in the endocrine system. Among all types of thyroid cancer, papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Long non-coding RNA (lncRNA) BRAF-activated non-protein-coding RNA (BANCR) is a 688-bp-long nucleotide transcript, which was first identified in melanoma. The function of BANCR in thyroid cancer remains unclear. The aim of the present study was to investigate whether BANCR is involved in the development of thyroid cancer. The results indicated that BANCR expression was increased in thyroid tumors compared with in adjacent normal tissues. Among cancer cell lines, the expression level of BANCR differed: BANCR expression in BCPAP cell lines was lower compared with that in CAL-62, WRO and FTC-133 cell lines. Overexpression of BANCR promoted the migration and invasion of BCPAP cells. Additionally, BANCR mediated epithelial-mesenchymal transition (EMT) by regulating the expression of epithelial (E)-cadherin, vimentin and neuronal (N)-cadherin. Overexpression of BANCR in BCPAP cells decreased the expression of E-cadherin and increased the expression of vimentin, N-cadherin, phospho (p)-c-Raf, p-extracellular-signal-regulated kinase (ERK)/mitogen activated protein kinase (MEK)1/2 and p-ERK1/2. Administration of U0126 inhibitor inhibited the regulation of phosphorylation levels by MEK1/2 and ERK1/2. Additionally, U0126 upregulated the expression of E-cadherin and downregulated the expression of vimentin. Taken together, the results of the present study suggest that BANCR induces EMT in PTC through the Raf/MEK/ERK signaling pathway.

Entities:  

Keywords:  BRAF-activated non-protein coding RNA; Raf; epithelial-mesenchymal transition; extracellular-signal-regulated protein kinase; mitogen-activated protein kinase kinase; papillary thyroid carcinoma

Year:  2018        PMID: 29552216      PMCID: PMC5840535          DOI: 10.3892/ol.2018.8017

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells.

Authors:  Feng Yang; Jianwei Bi; Xuchao Xue; Luming Zheng; Kangkang Zhi; Jide Hua; Guoen Fang
Journal:  FEBS J       Date:  2012-07-31       Impact factor: 5.542

3.  Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells.

Authors:  Chen Yang; Xu Li; Yu Wang; Le Zhao; Wei Chen
Journal:  Gene       Date:  2012-01-20       Impact factor: 3.688

Review 4.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

5.  Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expression.

Authors:  Lin Zhu; Pei-Cheng Xu
Journal:  Biochem Biophys Res Commun       Date:  2013-02-21       Impact factor: 3.575

6.  Genome-wide analysis of long noncoding RNA expression profile in papillary thyroid carcinoma.

Authors:  Xiabin Lan; Hao Zhang; Zhihong Wang; Wenwu Dong; Wei Sun; Liang Shao; Ting Zhang; Dalin Zhang
Journal:  Gene       Date:  2015-05-21       Impact factor: 3.688

Review 7.  The functional role of long non-coding RNA in human carcinomas.

Authors:  Ewan A Gibb; Carolyn J Brown; Wan L Lam
Journal:  Mol Cancer       Date:  2011-04-13       Impact factor: 27.401

8.  Long noncoding RNA HOTAIR promotes metastasis of renal cell carcinoma by up-regulating histone H3K27 demethylase JMJD3.

Authors:  Ming Xia; Lv Yao; Qiaoxia Zhang; Feng Wang; Hongbin Mei; Xiaoqiang Guo; Weiren Huang
Journal:  Oncotarget       Date:  2017-03-21

9.  Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation.

Authors:  Ruiya Li; Lingli Zhang; Lizhou Jia; Yan Duan; Yan Li; Lidao Bao; Na Sha
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

10.  BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor.

Authors:  Haitao Zheng; Meng Wang; Lixin Jiang; Haidi Chu; Jinchen Hu; Jinyao Ning; Baoyuan Li; Dong Wang; Jie Xu
Journal:  Cancer Res Treat       Date:  2015-08-12       Impact factor: 4.679

View more
  10 in total

Review 1.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.

Authors:  Heewa Shakib; Sadegh Rajabi; Mohammad Hossien Dehghan; Farideh Jalali Mashayekhi; Nahid Safari-Alighiarloo; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-08-04       Impact factor: 3.633

2.  LncRNAs as Potential Therapeutic Targets in Thyroid Cancer.

Authors:  Zeeshan Javed; Faiez Ahmed Shah; Sadegh Rajabi; Qamar Raza; Zaheer Iqbal; Mukhtar Ullah; Touqeer Ahmad; Bahare Salehi; Mehdi Sharifi-Rad; Raffaele Pezzani; Farooq Yaqoob; Haleema Sadia; Marcello Iriti; Javad Sharifi-Rad; William C Cho
Journal:  Asian Pac J Cancer Prev       Date:  2020-02-01

Review 3.  The Role of Long Non-Coding RNAs in Thyroid Cancer.

Authors:  Xuejiao Peng; Kun Zhang; Li Ma; Junfeng Xu; Weiqin Chang
Journal:  Front Oncol       Date:  2020-06-11       Impact factor: 6.244

4.  LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.

Authors:  Dong-Mei Wu; Shan Wang; Xin Wen; Xin-Rui Han; Yong-Jian Wang; Min Shen; Shao-Hua Fan; Zi-Feng Zhang; Qun Shan; Meng-Qiu Li; Bin Hu; Jun Lu; Gui-Quan Chen; Yuan-Lin Zheng
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

Review 5.  EMT Factors and Metabolic Pathways in Cancer.

Authors:  Ilias Georgakopoulos-Soares; Dionysios V Chartoumpekis; Venetsana Kyriazopoulou; Apostolos Zaravinos
Journal:  Front Oncol       Date:  2020-04-07       Impact factor: 6.244

6.  LncRNA BANCR Attenuates the Killing Capacity of Cisplatin on Gastric Cancer Cell Through the ERK1/2 Pathway.

Authors:  Xiang Miao; Yixiang Liu; Yuzhu Fan; Guoqiang Wang; Hongbo Zhu
Journal:  Cancer Manag Res       Date:  2021-01-12       Impact factor: 3.989

7.  lncRNA LIFR‑AS1 inhibits gastric carcinoma cell proliferation, migration and invasion by sponging miR‑4698.

Authors:  Jiangqiao Zhao; Xiaoning Li; Liping Fu; Na Zhang; Jiaping Yang; Jianhui Cai
Journal:  Mol Med Rep       Date:  2020-12-23       Impact factor: 2.952

Review 8.  The Impact of Non-coding RNAs in the Epithelial to Mesenchymal Transition.

Authors:  Bashdar Mahmud Hussen; Hamed Shoorei; Mahdi Mohaqiq; Marcel E Dinger; Hazha Jamal Hidayat; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Front Mol Biosci       Date:  2021-03-26

Review 9.  E-cadherin on epithelial-mesenchymal transition in thyroid cancer.

Authors:  Xiaoyu Zhu; Xiaoping Wang; Yifei Gong; Junlin Deng
Journal:  Cancer Cell Int       Date:  2021-12-20       Impact factor: 5.722

10.  METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.

Authors:  Xiaoping Zhang; Dan Li; Chengyou Jia; Haidong Cai; Zhongwei Lv; Bo Wu
Journal:  Cell Death Dis       Date:  2021-06-15       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.